MAB8694
Anti-Hepatitis C Virus Antibody, NS5A
Chemicon®, from mouse
別名:
HCV
製品名
Anti-Hepatitis C Virus Antibody, NS5A, Chemicon®, from mouse
biological source
mouse
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
isotype
IgG1
shipped in
wet ice
Quality Level
Application
ELISA
Immunofluorescence
RIA
Western Blot
Optimal working dilutions must be determined by end user.
Immunofluorescence
RIA
Western Blot
Optimal working dilutions must be determined by end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-Hepatitis C Virus Antibody, NS5A is validated for use in ELISA, IF, WB, IH for the detection of Hepatitis C Virus.
Biochem/physiol Actions
Specific to HCV NS5A
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Immunogen
Recombinant protein to NS5A
Physical form
Format: Purified
Liquid 0.02M PB, 0.25M NaCl, 0.1% sodium azide
Preparation Note
Store at 2 to 8°C for up to 12 months from date of receipt.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
保管分類
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Enhanced Ca2+ leak from ER Ca2+ stores induced by hepatitis C NS5A protein.
Lisbeth C Robinson, Jonathan S Marchant, Lisbeth C Robinson, Jonathan S Marchant
Biochemical and biophysical research communications null
Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme.
Chang Ho Lee,Ji Hyun Kim,Hee Won Kim,Heejoon Myung,Seong-Wook Lee
Nucleic Acid Therapeutics null
Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee, CH; Lee, YJ; Kim, JH; Lim, JH; Kim, JH; Han, W; Lee, SH; Noh, GJ; Lee, SW
Journal of virology null
Shao-Ru Chen et al.
Molecules (Basel, Switzerland), 21(10) (2016-10-19)
Hepatitis C virus (HCV) infects 200 million people worldwide, and 75% of HCV cases progress into chronic infections, which consequently cause cirrhosis and hepatocellular carcinoma. HCV infection is treated with currently considered standard drugs, including direct anti-viral agents (DAAs), alone
Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1?.
Matsui, C; Shoji, I; Kaneda, S; Sianipar, IR; Deng, L; Hotta, H
Journal of virology null
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| MAB8694 | 04053252504709 |
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）